, which inhibits the cyclin-dependent kinases Summary (reviewed in Ko and Prives, 1996) . p53R2, which is the ribonucleotide reductase gene, has been isolated and Through direct cloning of p53 binding sequences from shown to play a crucial role for DNA repair by p53 after human genomic DNA, we have isolated a novel gene, DNA damage (Tanaka et al., 2000) . As candidates to designated p53AIP1 (p53-regulated Apoptosis-Inducmediate p53-dependent apoptosis, several p53 target ing Protein 1), whose expression is inducible by wildgenes including Bax and PIG genes have been sugtype p53. Ectopically expressed p53AIP1, which is logested (Miyashita and Reed, 1995; Polyak et al., 1997). calized within mitochondria, leads to apoptotic cell However, many putative apoptosis-inducing p53 target death through dissipation of mitochondrial ⌬⌿m. We genes do not induce apoptosis when expressed alone have found that upon severe DNA damage, Ser-46 on (Polyak et al., 1997). p53 is phosphorylated and apoptosis is induced. In
We have been attempting to isolate novel p53 target addition, substitution of Ser-46 inhibits the ability of genes by two different strategies. One is a differential display method using a cell line in which the expression p53 to induce apoptosis and selectively blocks expresof an exogenous wild-type p53 gene can be regulated sion of p53AIP1. Our results suggest that p53AIP1 is under the control of the lactose operon (Takei et al., likely to play an important role in mediating p53-depen-1998). By this approach, we previously isolated three dent apoptosis, and phosphorylation of Ser-46 regunovel p53-inducible genes, TP53TG1, TP53TG3, and lates the transcriptional activation of this apoptosisp53R2 ( Here we report yet another novel p53 target gene, p53AIP1, which is involved in the p53-dependent aponot shown). The entire 40 kb genomic sequence contained in cos38 was determined by shot-gun sequencptosis pathway. Moreover, we provide evidence that Ser-46 of p53 is phosphorylated in response to DNA ing. Analysis with the GRAIL2 computer program (Solovyev et al., 1994) predicted 12 possible exons with damage in vivo, and it plays a pivotal role for apoptotic signaling by p53 through regulating the transcriptional "excellent" or "good" scores; the GENSCAN program (Burge and Karlin, 1997) also predicted 12 possible exactivation of an apoptosis-inducing gene, p53AIP1.
ons. Among them, four were predicted as candidate exons by both programs; hence, a total of 20 candidate exonic segments were present in the vicinity of putative Results p53 binding sequences. We synthesized oligonucleotides corresponding to the candidate exons and performed Isolation of a Novel p53-Inducible exon connection experiments, using cDNA reverse tranTranscription Unit scribed from thymus mRNA. This effort produced a 474 Using a yeast enhancer trap system, we isolated a numbp cDNA fragment consisting of the two predicted exons ber of human genomic sequences that appear to acti-(data not shown). vate transcription in a p53-dependent manner (p53-tagged sites; Tokino et al., 1994) . A 190 bp DNA fragment corresponding to one of those sites (clone TP53-41) was Isolation of the p53AIP1 Gene sequenced and found to contain a putative p53 binding To isolate a full-length cDNA of the gene represented by sequence (BDS; Figure 1C ). To isolate a larger genomic the exon-connected fragment, U373MG (glioblastoma) region including this fragment, we screened a human cells were infected for 48 hr with a replication-defective cosmid library using clone TP53-41 as a probe and isoadenovirus engineered to express wild-type p53 (Adlated a cosmid-designated TP53-cos38, which we p53), and polyA RNA was isolated from the cells. Northern blot analysis using the 474 bp cDNA fragment as a mapped to chromosome 11q24 by FISH analysis (data probe ( Figure 1A ) detected 0.8 kb and 2.7 kb transcripts Subcellular Localization of p53AIP1 that were strongly induced in the U373MG cells by infecThe PSORT motif prediction program (Nakai and Kanetion with Ad-p53. However, Northern blotting analysis hisa, 1992) indicated the presence of a potential mitousing mRNAs from 16 normal human tissues revealed chondrial targeting sequence at the N termini of expression of the gene only in thymus (data not shown).
p53AIP1␣ and p53AIP1␤, suggesting that p53AIP1 might We constructed a cDNA library using the poly(A) ϩ RNA be a mitochondrial protein. We constructed a plasmid from transfected U373MG cells, screened this library clone, pCAGGS/C-HA-p53AIP1␣, that was designed to using the exon-connected fragment as a probe, and express p53AIP1␣ with an HA tag at the C-terminal end. obtained 20 positive clones. Sequencing of these cDNA
We transfected this plasmid DNA into COS-7 cells and clones identified three major transcripts, designated ␣, detected the tagged proteins by immunofluorescent ␤, and ␥, which consisted respectively of 806, 777, and staining. As shown in Figure 2A , p53AIP1␣ was strongly 2659 nucleotides with open reading frames encoding stained in the perinuclear region and appeared as a 124, 86, and 108 amino acids ( Figure 1B) . Computer dotted pattern in cytoplasm. When we stained mitoanalysis using the FASTA (Pearson, 1990) and BLAST chondria using an anti-mitochondrial antibody, the programs (Altschul et al., 1990) detected no significant green signal of p53AIP1 coincided exactly with the red homology between these three products and any known one of mitochondria, confirming a mitochondrial locaprotein in the public database. A comparison of genomic tion of p53AIP1 protein. Mitochondrial localization of and cDNA sequences defined the genomic structure of endogenous p53AIP1 after irradiation of gamma ray was this novel gene, which we designated p53AIP1 on the also confirmed using anti-p53AIP1 antibody in MCF-7 basis of the functional characteristics described below. cells ( Figure 2B ). The gene spans an 8.2 kb genomic region and consists of five exons ( Figure 1C) Figure 2C ). While p21 Waf1 exprestest whether p53 was able to bind to oligonucleotides sion in NHDF cells reached a maximum after 6 hr of corresponding to the p53BDS sequence in intron 1 of exposure to either adriamycin or ionizing radiation, maxthe p53AIP1 gene. As shown in Figure 1D , the site bound imum levels of p53AIP1 were observed only after 24 hr a molecule in nuclear extracts of H1299 (lung carcinoma) of exposure. These results suggest that although cells infected with Ad-p53. When we added anti-p53 p53AIP1 is induced in response to DNA damage, its antibodies (PAb421 and/or PAb1801) to the mixture, adinduction is likely to be quite different from that of ditional shifted bands were observed. Unlabeled selfp21
Waf1
. oligonucleotide but not a random oligonucleotide inhibited these interactions. The results suggested that p53 p53AIP1 Induces Apoptosis through Dissipation protein could in fact bind to p53BDS in vitro. To furof Mitochondrial ⌬⌿m ther evaluate the transcription-enhancing activity of We performed colony formation assays to investigate the binding sequences, we performed a reporter assay whether p53AIP1 itself functions as growth suppreswith the heterologous luciferase gene fused to one sor. After constructing mammalian expression vectors [p53BDS(1ϫ)] or two copies [p53BDS(2ϫ)] of p53BDS (pCAGGS/N-HA-p53AIP1␣, ␤, and ␥) containing the enupstream of the SV40 promoter (SV40-BDS) of the tire coding sequence of each transcript, we confirmed pGL3 promoter vector. Transfection of p53BDS(1ϫ), by immunoblotting that each was expressed in mammap53BDS(2ϫ), or control (SV40 promoter without a p53 lian cells, using rat anti-HA tag monoclonal antibody binding site) vector into colon cancer cells (SW480) lack-(3F10, Boehringer; data not shown). To confer geneticin ing wild-type p53 did not enhance luciferase activity. resistance, the pcDNA3.1(ϩ) vector was cotransfected However, cotransfection of p53BDS(1ϫ) or p53BDS(2x) into T98G (glioblastoma) cells with the p53AIP1␣, ␤, or with the wild-type p53 (wt-p53) expression plasmid in-␥ expression plasmids. Transfected cells were grown in creased luciferase activity significantly, while cotransthe presence of geneticin for 2 weeks. Figure 3A shows fection with mutant p53 (mt-p53) failed to do so (Figure that introduction of pCAGGS/N-HA-p53AIP1␣ or ␤ re-1E). Heterogeneous reporter vectors (intron 1-wt or insulted in substantial growth suppression, as seen by a tron 1-mt) were constructed by cloning a 500 bp seg-3-to 4-fold decrease in the number of geneticin-resisment corresponding to intron 1 of the p53AIP1 gene tant colonies. Growth suppression was also observed (intron 1-wt), or the same 500 bp segment (intron 1-mt) when HA tag was inserted into the C terminus of the containing a mutated p53BDS sequence, upstream of pCAGGS vector (pCAGGS/C-HA-p53AIP1␣ or ␤; data the SV40 minimal promoter, respectively. Intron 1-wt or not shown). Although we tried to establish a stable transintron 1-mt reporter vectors were cotransfected into the formant that would overexpress p53AIP1, we were un-SW480 cell line, along with either wt-p53 or mt-p53 exsuccessful, most likely because of the cytotoxity obpression vectors. Luciferase activity of intron 1-wt but served in the colony formation assays. not intron 1-mt was increased by cotransfection of the Its late induction by p53, its growth-suppressing activwt-p53 expression vector ( Figure 1E ), while mt-p53 did ity, and its mitochondrial localization prompted us to not enhance the activity of intron 1-wt reporter vector speculate that p53AIP1 might play an important role in ( Figure 1E) . Thus, the binding site we identified serves p53-dependent apoptosis. We performed TUNEL analyas a p53 response element, leading to the conclusion that p53AIP1 is a bona fide direct target of p53.
sis to investigate whether introduction of exogenous To investigate the mechanism by which p53AIP1 inAs described in the Introduction, Ser-46 is a phosphorylation site that may regulate the apotosis-inducing ability duces apoptosis, we examined the mitochondrial ⌬⌿m, an indicator of electrochemical gradient across the mitoof p53. Thus, we generated antibodies to specifically recognize phospho-Ser-46. We first investigated phoschondrial inner membrane, using Mito-tracker CMXRos (Molecular Probes). Almost all cells expressing p53AIP1␣ phorylation of several different sites on p53 after treatment of MCF7 cells with different DNA damaging agents, revealed dissipation of mitochondrial ⌬⌿m at 24 hr after transfection ( Figure 3C expression of p53AIP1 was greatly impaired in S46 muwas performed using a synthetic reporter construct contants ( Figure 8B ). These results indicate that phosphorytaining the p53AIP1-derived p53-responsive element lation of Ser-46 regulates induction of p53AIP1 expresupstream of the luciferase reporter, as described presion specifically.
viously (Tanaka et al., 2000) . p53AIP1 and p21 Waf1 reSince the expression level of p53 is mainly regulated porter constructs were transiently transfected into by protein degradation, we examined whether phosphy-SAOS-2 cells along with either p53WT or p53S46A exlation of Ser-46 changes the half-life of p53 protein or pression plasmids. As shown in Figure 8C , transactivanot. p53WT and p53S46A expression plasmids were tion of p53AIP1 by p53S46A was significantly lower transiently transfected into H1299 cells and a pulsewhen compared to p53WT, although there was no differchase experiment was performed. One set of cells was ence in p21 Waf1 transactivation. We further performed treated with IR (30 Gy) at 18 hr after transfection to EMSA experiments using nuclear extracts isolated from examine prolongation of half-life after DNA damage.
H1299 cells, which were transfected with either wildBoth p53WT and p53S46A had similar half lives of about type p53 or mutant p53 (S46A) expression vector. As ‫58ف‬ min in our system (data not shown), consistent with shown in Figure 8D , binding activity of the mutant p53 the fact that their expression levels as determined by (S46A) protein to p53AIP1-BDS but not to p21 WAF1 -immunoblotting were almost equal among p53WT and BDS was impaired. These data suggest residue S46 mutants ( Figure 8A . The latter occurred immediately after p53 inducstrated that transfection of p53AIP1 or infection with Ad-p53AIP1 induces massive apoptotic cell death in tion, but p53AIP1 was induced only 6-12 hr later. This time difference was puzzling, given that both genes are T98G cells, suggesting that p53AIP1 might mediate apoptosis by regulation of mitochondrial ⌬⌿m. Moreover, direct targets for p53. To explain this dichotomy, we hypothesize that posttranslational modification of p53 inhibition of p53AIP1 induction by an antisense oligonucleotide strikingly blocked Ad-p53-induced apoptosis.
protein might determine its affinity for specific p53 binding sequences present in different target genes and The Bax gene product, which is involved in apoptosis, is also upregulated by p53 (Miyashita and Reed, 1995) . that the status of p53 modification soon after DNA damage might be quite different from that in a later phase. This protein translocates from the cytosol to mitochondria during apoptosis and induces release of cytoThis is supported by our observation that binding to the p53AIP1 site is affected specifically by mutation of chrome c, and Bax release can be inhibited by Bcl-2 (Green and Reed, 1998). However, p53-induced apoSer-46. In summary, we propose the model shown in Figures  ptosis is unlikely to depend on chloride [p-APMSF], and a protease inhibitor cocktail consisting of 2.5 g/ml pepstatin A, 2.5 g/ml antipain, 2.5 g/ml chymostatin, for 2 hr at room temperature. These antibodies, rat anti-HA antibody, and mouse anti-human mitochondria antibody were stained with a 0.25 mg/ml leupeptin, and 0.25 mg/ml antipain. Collected cells were allowed to lyse with sonication on ice. The homogenate was centrigoat anti-rat secondary antibody conjugated to FITC and a goat antifuged for 5 min in a microcentrifuge at 4ЊC and the supernatants mouse secondary antibody conjugated to rhodamine, respectively, were collected and boiled in SDS sample buffer. Each 50 g of and viewed with an ECLIPSE E600 microscope (Nikon).
SDS sample was loaded onto 10% and 12.5% SDS-PAGE gels To perform phospho-Ser-46 immunostaining of p53 in cells miand blotted onto PVDF membranes (Amersham Pharmacia Biotech). croinjected with either wild-type p53 or mutant p53 (S46A) at 18 hr Anti-p21 Waf1 antibody was purchased from Transduction Laboraafter microinjection, cells were fixed in 4% paraformaldehyde and tories. Anti-mdm2 antibody (Ab-1) and anti-p53 antibodies (DO-1, permealized with 0.1% Triton X-100 in PBS for 3 min at 4ЊC. Cells Pab421, and Pab1801) were purchased from Oncogene Research were incubated with blocking solution containing 3% BSA in PBS for Products. Anti-p-Ser-15 and Ser-20 of p53 antibody were described 60 min at room temperature. Subsequently, the cells were incubated previously (Shieh et al., 1997 (Shieh et al., , 1999 . A similar approach was used with anti-p53 monoclonal antibody DO-1 (diluted 1:100 in blocking for generating the anti-p-Ser-46 polyclonal antibody. In this case, the solution) and anti-phospho-Ser-46 of p53 rabbit polyclonal antibody phosphorylated peptide MDDLMLS(PO 3 H 2 )PDDIEQC (amino acids (diluted 1: 50) for 2 hr at room temperature. The primary antibodies 40-52) was used for immunization of rabbits. These phospho-spewere stained with a goat anti-mouse secondary antibody conjugated cific antibodies were subsequently purified through antigen affinity to FITC and a goat anti-rabbit secondary antibody conjugated to columns. Polyclonal antibodies against p53AIP1 protein were generrhodamine (diluted 1: 1000) for 1 hr and viewed with an ECLIPSE ated in rabbits using a synthetic peptide of C termini of p53AIP1. E600 microscope (Nikon).
Protein 
